SCHEMBL1659093

SCHEMBL1659093

O=C(O)c1scc(CF)c1-c1ccccc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.36
PTPRC P08575 2/20 0.35
PTPN2 P17706 1/20 0.35
PTPN1 P18031 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CDC7 O00311 1/20 0.35
DBF4 Q9UBU7 1/20 0.35
GRIA4 P48058 1/20 0.35
ABCC4 O15439 1/20 0.34
LMNA P02545 1/20 0.34
GAA P10253 1/20 0.34
TSHR P16473 1/20 0.34
PTGS1 P23219 1/20 0.34
HTT P42858 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
HPGDS O60760 1/20 0.34
DHODH Q02127 1/20 0.34
KDM4E B2RXH2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7933440 0.75 BCAT2 (0.44) ALDH1A1SMN1; SMN2CDC7DBF4GRIA4
SCHEMBL6271885 0.74 ALDH1A1 (0.45) ALDH1A1CYP2C9CYP2C19SMN1; SMN2CDC7
SCHEMBL6277250 0.74 POLB (0.50) ALDH1A1CYP2C19SMN1; SMN2CDC7DBF4
SCHEMBL8423076 0.73 BACE1 (0.43) ALDH1A1PTPRCPTPN2PTPN1SMN1; SMN2
SCHEMBL27605106 0.70 KMO (0.44) ALDH1A1PTPN2PTPN1SMN1; SMN2GAA
SCHEMBL4561918 0.69 BCAT2 (0.43) ALDH1A1CYP2C9SMN1; SMN2CDC7DBF4
SCHEMBL69825 0.68 GRIA4 (0.50) ALDH1A1PTPRCPTPN2PTPN1CYP2C9
SCHEMBL1660355 0.67 KMT2A (0.36) ALDH1A1PTPN1CYP2C19SMN1; SMN2LMNA
SCHEMBL1659091 0.66 PTPRC (0.45) PTPRCPTPN2PTPN1DHODHKMT2A
Biphenyl SCHEMBL27893795 0.65 LMNA (0.56) ALDH1A1PTPN1SMN1; SMN2ABCC4LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2307394-A2 NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME Amorepacific Corporation (KR) 2011-04-13 EP disclosed
WO-2010002209-A2 NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AMOREPACIFIC CORPORATION (KR) 2010-01-07 WO disclosed